000 01541 a2200433 4500
005 20250514043114.0
264 0 _c20030123
008 200301s 0 0 eng d
022 _a0392-2936
040 _aNLM
_beng
_cNLM
100 1 _aSajdak, S
245 0 0 _aBleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
_h[electronic resource]
260 _bEuropean journal of gynaecological oncology
_c2002
300 _a325-6 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdenocarcinoma
_xcomplications
650 0 4 _aAdministration, Intravaginal
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aEndometrial Neoplasms
_xcomplications
650 0 4 _aEthamsylate
_xadministration & dosage
650 0 4 _aFactor VII Deficiency
_xcomplications
650 0 4 _aFactor VIIa
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHemostatics
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aMandibular Neoplasms
_xcomplications
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aRecombinant Proteins
650 0 4 _aSarcoma
_xcomplications
650 0 4 _aTranexamic Acid
_xadministration & dosage
650 0 4 _aUterine Hemorrhage
_xdrug therapy
650 0 4 _aVaginal Neoplasms
_xcomplications
700 1 _aMoszynski, R
700 1 _aOpala, T
773 0 _tEuropean journal of gynaecological oncology
_gvol. 23
_gno. 4
_gp. 325-6
999 _c12095436
_d12095436